Skip to main content

Hoelscher Paul W.'s Form 4 filing

Horizon Therapeutics Public Ltd Co (HZNP) · filed Apr 8, 2022

Accession no.
0001209191-22-023845
Filed
Apr 8, 2022
Trade date
Apr 6, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $33.8M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hoelscher Paul W.CIK 0001611468Officer (EVP, CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 6, 2022Ordinary SharesMOption exerciseAcquired+30,275$15.96+$483,18931,324Direct
Apr 6, 2022Ordinary SharesMOption exerciseAcquired+185,060$22.14+$4,097,228.4216,384Direct
Apr 6, 2022Ordinary SharesSSaleDisposed−215,335$110.01−$23,689,003.351,049Direct
Apr 6, 2022Ordinary SharesSSaleDisposed−91,710$110.01−$10,089,017.166,673Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 6, 2022Ordinary SharesMOption exerciseDisposed−30,275$0.00$00Direct
Apr 6, 2022Ordinary SharesMOption exerciseDisposed−185,060$0.00$086,424Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)